Physician profile
Charles Modlin
NPI 1578527891
$4,993.08
in general payments reported to CMS, 2019-2025
7 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,350 · 2021: $2,580 · 2022: $940 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,925.15 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,680.00 | 2021 | |
| Alnylam Pharmaceuticals INC. | $127.76 | 2022 | |
| Dynavax Technologies Corporation | $112.00 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $65.67 | 2022 | |
| Janssen Biotech, INC. | $47.58 | 2025 | Erleada |
| Boston Scientific Corporation | $34.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Modlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.